The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
The effect of adjuvant chemotherapy for patients with adverse pathology after neoadjuvant chemotherapy for muscle invasive bladder cancer.
 
William P. Parker
No Relationships to Disclose
 
Elizabeth B. Habermann
No Relationships to Disclose
 
Courtney N. Day
No Relationships to Disclose
 
Harras B. Zaid
No Relationships to Disclose
 
Igor Frank
No Relationships to Disclose
 
Robert Houston Thompson
Patents, Royalties, Other Intellectual Property - Patent for B7-H1 and survivin as prognostic markers in renal cell carcinoma.
 
Matthew K. Tollefson
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - Astellas Medivation
 
Lance C. Pagliaro
No Relationships to Disclose
 
Jeffrey Karnes
No Relationships to Disclose